Bart Krist

Bart Krist
Adam Mickiewicz University in Poznań | UAM · Developmental Epigenetics

Doctor of Biotechnology

About

25
Publications
12,818
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
472
Citations
Introduction
Dutch doctor obtained a PhD at the Jagiellonian University in Kraków, currently working at the laboratory of Developmental Epigenetics on the faculty of Biology, Adam Mickiewicz University in Poznań
Additional affiliations
September 2021 - present
Adam Mickiewicz University in Poznań
Position
  • PostDoc Position
Description
  • postdoc position on the project “The role of 3D genome folding in the establishment of keratinocyte-specific promoter-enhancer network.”
January 2020 - July 2021
Institute of Bioorganic Chemistry, Polish Academy of Sciences
Position
  • PostDoc Position
October 2017 - November 2019
Adam Mickiewicz University in Poznań
Position
  • PostDoc Position
Description
  • Targeted inhibition of STATs and IRFs as a novel treatment strategy in cardiovascular disease
Education
August 2013 - July 2017
Jagiellonian University
Field of study
  • Medical Biotechnology
September 2011 - July 2013
Vrije Universiteit Amsterdam
Field of study
  • Master of Oncology
September 2008 - July 2011
University of Applied Sciences Leiden
Field of study
  • Cyto- and Histology

Publications

Publications (25)
Preprint
Huntington's disease (HD) is a polyglutamine neurodegenerative disease involving pathogenesis within the striatum and cerebral cortex and a neurodevelopmental component, particularly in juvenile HD form (JOHD). We established a fused HD dorsal-ventral system, imitating the cortex and striatum interaction in a single organoid to discover neurodevelo...
Conference Paper
The impact of Huntington’s Disease (HD) on neurodevelopment is still not fully elucidated. Our latest study demonstrates a new fused dorso-ventral forebrain organoid model of HD for providing new insights into the altered cellular organization of brain structures in HD neurodevelopment. The dorso-ventral organoids from juvenile HD or control iPSC m...
Article
Full-text available
Polyglutamine (PolyQ) diseases are neurodegenerative disorders caused by the CAG repeat expansion mutation in affected genes resulting in toxic proteins containing a long chain of glutamines. There are nine PolyQ diseases: Huntington’s disease (HD), spinocerebellar ataxias (types 1, 2, 3, 6, 7, and 17), dentatorubral-pallidoluysian atrophy (DRPLA),...
Preprint
Full-text available
(PolyQ) diseases are neurodegenerative disorders caused by the CAG 30 repeat expansion mutation in affected genes resulting in toxic proteins containing a long chain of glutamines. There are nine PolyQ diseases: Huntington's disease (HD), spinocerebellar ataxias (types 1, 2, 3, 6, 7, and 17), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal...
Article
The expression of the matricellular protein periostin has been associated with glioma progression. In previous work we found an association of periostin with glioma angiogenesis. Here, we screen gliomas for POSTN expression and identify the cells that express periostin in human gliomas. In addition, we study the role of periostin in an in vitro mod...
Article
Full-text available
Magnetic nanoparticles are extensively studied for their use in diagnostics and medical therapy. The behavior of nanoparticles after adding them to cell culture is an essential factor (i.e., whether they attach to a cell membrane or penetrate the membrane and enter into the cell). The present studies aimed to demonstrate the application of electron...
Conference Paper
BACKGROUND The expression of the matricellular protein periostin has recently been associated with glioma progression and angiogenesis. The aim of the present study was to identify the cellular source of periostin expression in human gliomas and to study the role of periostin in an in vitro model for angiogenesis. MATERIAL AND METHODS The expressi...
Article
Aims: MicroRNA-378a, highly expressed in skeletal muscles, was demonstrated to affect myoblasts differentiation and to promote tumor angiogenesis. We hypothesized that miR-378a could play a pro-angiogenic role in skeletal muscle and may be involved in regeneration after ischemic injury in mice. Methods and results: Silencing of miR-378a in murine...
Article
Full-text available
Aims: MicroRNA-378a, highly expressed in skeletal muscles, was demonstrated to affect myoblasts differentiation and to promote tumor angiogenesis. We hypothesized that miR-378a could play a pro-angiogenic role in skeletal muscle and may be involved in regeneration after ischemic injury in mice. Methods and results: Silencing of miR-378a in murin...
Article
Full-text available
Interferon regulatory factors (IRFs) are a family of homologous proteins that regulate the transcription of interferons (IFNs) and IFN-induced gene expression. As such they are important modulating proteins in the Toll-like receptor (TLR) and IFN signaling pathways, which are vital elements of the innate immune system. IRFs have a multi-domain stru...
Article
Vascular endothelial growth factor (VEGF), as an endothelial cell-specific mitogen, is crucial for new blood vessels formation. Atherosclerosis affecting the cardiovascular system causes ischemia and functio laesa in tissues supplied by the occluded vessels. When such a situation occurs in the lower extremities, it causes critical limb ischemia (CL...
Article
Vascular endothelial growth factor (VEGF), as an endothelial cell-specific mitogen, is crucial for new blood vessels formation. Atherosclerosis affecting the cardiovascular system causes ischemia and functio laesa in tissues supplied by the occluded vessels. When such a situation occurs in the lower extremities, it causes critical limb ischemia (CL...
Article
Full-text available
Rhabdomyosarcoma (RMS) is an aggresive soft tissue cancer characterized by disturbed myogenic differentiation. Here we report a role for the oxidative stress response factor HO-1 in progression of RMS. We found that HO-1 was elevated and its effector target miR-206 decreased in RMS cell lines and clinical primary tumors of the more aggressive alveo...
Article
MicroRNA 378a (miR-378a) is a short, non-coding RNA molecule which plays post-transcriptional regulatory roles in metabolism, muscle development, muscle regeneration and in angiogenesis. We therefore postulated a role of miR-378a in regenerative neovascularization in ischemic tissue. Comparing blood flow recovery in response to hind limb ischemia...
Poster
Full-text available
MiR-378a is a microRNA highly expressed in skeletal muscles and plays a role in muscle differentiation and cell metabolism. Recently it was found to stimulate also tumor angiogenesis. However, no data exists on the involvement of miR-378a in regenerative revascularization of ischemic tissues. To test such a hypothesis we differentiated murine myobl...
Article
Full-text available
MicroRNA-378a (miR-378a, previously known as miR-378) is one of the small noncoding RNA molecules able to regulate gene expression at posttranscriptional level. Its two mature strands, miR-378a-3p and miR-378a-5p, originate from the first intron of the peroxisome proliferator-activated receptor gamma, coactivator 1 beta ( ppargc1b ) gene encoding P...
Poster
Full-text available
miR378 is a microRNA commonly found in high levels is muscle tissue and is known to play roles in metabolism, muscle differentiation and it was found to play an antagonistic role together with hemeoxigenase in tumor angiogenesis. To test our hypothesis of the involvement of miR378 in blood vessel formation and regeneration processes in muscles we u...
Article
Full-text available
Purpose: Hot-spot mutations in the promoter region of telomerase reverse transcriptase (TERT promoter mutations) occur frequently in cutaneous and conjunctival melanoma and are exceedingly rare in uveal melanoma. No information is available on the presence of these mutations in the conjunctival melanocytic precursor lesion primary acquired melanos...

Questions

Questions (8)
Question
Dear fellow scientists,
For our research in skin development we are collecting mouse embryos at different time points during embryogenesis. We now got an idea to do some further analysis for which it would be good if we would not have to use whole embryos, but only the epidermal layer. The later stages of embryogenesis we can dissect without too much problem, but earlier stages give me great difficulty. Therefore, I would like to ask if anyone has a good working protocol for epidermis isolation from E11,5 (or around this stage) mouse embryos?
Thank you in advance!
Question
Hello everyone,
We are currently in the proces of ordering a new cel cluture incubator for our brain organoid cel culture. Now I never really had any preference for a specific type of incubator, but perhaps it is good to think about this before simply purchasing 'the cheapest option'....
So, which incubator is in your opinion the best for growing neurons, spheres and organoids? and why?
Question
For our research on Huntington disease, we use a murine model with human muHTT and wtHTT on a Hdh-/- background. These ice unfortunately do not breed well, with only three litters in our breeding pairs in the last year...
Do you maybe have any tips for improving breeding capacity? We already changed from breeding pairs (1 male and 1 female) to a 'harem' system, with 3-4 females for 1 male.
All ideas are welcome.
Question
Dear all,
I am trying to optimize siRNA transfection of primary sorted satellite cells from mice. Previously I had a lot of succes with transfecting murine myoblast cell lines with JetPrime (Polyplus), and now we want to bring our research into the primary isolated cells. However, collegues of mine have had very poor results transfecting SCs with JetPrime, Lipofectamine, siPort Neofx, and PEI  - low efficiency or high toxicity made succesful transfection previously impossible.
Does anyone have any experience with successful primary sattelite cell transfection?  which protocol you used?  Do you have any suggestions for further optimization? 
Thank you all in advance!
Question
Hi everyone,
I am operating mice to induce ischemia in the left hindlimb by ligating the femoral artery. The procedure is well established i our laboratory and after three years of working on the project I might say we got quite experienced with it.
However, recently we see that mice of one certain genotype develop swelling of the right (=not operated) hindlimb. Infection is not likely, as the rest of the mice (operate leg, eyes, etc) are not inflammated, red, or swollen...
Does anyone has an idea what might be the reason of this swelling?
Question
I would like to treat HUVEC cells with conditioned medium from transfected C2C12 cells. I was just wondering if C2C12 cells would survive if I would put them in MCDB-131 medium (which our lab uses to culture HUVEC) for 24hrs... does anyone has experience with that? or would it be more safe to condition DMEM medium and then dillute this in MCDB? - I would love to hear your thoughts and tips on this
Question
I am planning to perform a global analysis of gene expression for the first time. I will be focusing on angiogenic factors. We are using mouse samples. Does anyone have any experience with such analysis? What are your tips and recommendations? PCR array, macroarray or microarray and from which company?
Question
In our lab we use Ottix Plus and Ottix shaper dehydration and deparrafination media, as more safe substitutes of Ethanol and Xylene.
However, when I was fixing and staining some muscle samples, I saw the morphology was quite bad. Can this be because of ottix, or is my fixation (10% formalin solution for 48h) the cause?

Network

Cited By